lg 100268 and lg 1506

lg 100268 has been researched along with lg 1506 in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ardecky, RJ; Boehm, MF; Chen, JH; Crombie, DL; Etgen, GJ; Faul, MM; Faulkner, AL; Grese, TA; Heyman, RA; Karanewsky, DS; Klausing, K; Leibowitz, MD; Liu, S; Mais, DA; Mapes, CM; Marschke, KB; Michellys, PY; Ogilvie, KM; Reifel-Miller, A; Rungta, D; Thompson, AW; Tyhonas, JS1
Ardecky, RJ; Boehm, MF; Chen, JH; D'Arrigo, J; Grese, TA; Karanewsky, DS; Leibowitz, MD; Liu, S; Mais, DA; Mapes, CM; Michellys, PY; Montrose-Rafizadeh, C; Ogilvie, KM; Reifel-Miller, A; Rungta, D; Thompson, AW; Tyhonas, JS1
Ardecky, RJ; Boehm, MF; Chen, JH; Grese, TA; Karanewsky, DS; Leibowitz, MD; Liu, S; Mais, DA; Mapes, CM; Michellys, PY; Ogilvie, KM; Reifel-Miller, A; Rungta, D; Thompson, AW; Tyhonas, JS; Yumibe, N1
Boehm, MF; D'Arrigo, J; Grese, TA; Karanewsky, DS; Leibowitz, MD; Mais, DA; Mapes, CM; Michellys, PY; Reifel-Miller, A; Rungta, D1

Other Studies

4 other study(ies) available for lg 100268 and lg 1506

ArticleYear
Novel (2E,4E,6Z)-7-(2-alkoxy-3,5-dialkylbenzene)-3-methylocta-2,4,6-trienoic acid retinoid X receptor modulators are active in models of type 2 diabetes.
    Journal of medicinal chemistry, 2003, Jun-19, Volume: 46, Issue:13

    Topics: Animals; Blood Glucose; Caprylates; Diabetes Mellitus, Type 2; Hypoglycemic Agents; Insulin Resistance; Male; Mice; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Retinoic Acid; Retinoid X Receptors; Structure-Activity Relationship; Transcription Factors

2003
Design, synthesis, and structure-activity relationship studies of novel 6,7-locked-[7-(2-alkoxy-3,5-dialkylbenzene)-3-methylocta]-2,4,6-trienoic acids.
    Journal of medicinal chemistry, 2003, Sep-11, Volume: 46, Issue:19

    Topics: Alkenes; Animals; Benzene Derivatives; Caprylates; Cell Line; Chlorocebus aethiops; Dose-Response Relationship, Drug; Drug Design; Drug Synergism; Hypoglycemic Agents; Male; Mice; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Retinoic Acid; Retinoid X Receptors; Rosiglitazone; Structure-Activity Relationship; Thiazoles; Thiazolidinediones; Thyroxine; Transcription Factors; Transfection; Triglycerides

2003
Design and synthesis of novel RXR-selective modulators with improved pharmacological profile.
    Bioorganic & medicinal chemistry letters, 2003, Nov-17, Volume: 13, Issue:22

    Topics: Animals; Binding, Competitive; Cell Line; Coumarins; Drug Design; Kinetics; Male; Mice; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Retinoic Acid Receptor gamma; Retinoid X Receptors; Transcription Factors; Tretinoin

2003
Design, synthesis and structure-activity relationship of novel RXR-selective modulators.
    Bioorganic & medicinal chemistry letters, 2004, Mar-22, Volume: 14, Issue:6

    Topics: Drug Design; Protein Binding; Receptors, Retinoic Acid; Retinoid X Receptors; Structure-Activity Relationship; Transcription Factors; Tretinoin

2004